Case report: Aggressive NSCLC with partial BRG-1 deficiency and KRAS G12C mutation: a case study and treatment challenges
2024
Case Study of Aggressive Lung Cancer with Partial BRG-1 Deficiency
Sample size: 1
publication
Evidence: low
Author Information
Author(s): Jin Chengwei, Ge Hong, Hou Dongsheng, Li Jing, Tan Mingming
Primary Institution: Zibo Central Hospital, Zibo, China
Hypothesis
What are the clinical implications of partial BRG-1 deficiency in lung cancer?
Conclusion
Partial BRG-1 deficiency may lead to aggressive clinical behavior, similar to complete BRG-1 loss.
Supporting Evidence
- BRG-1 deficiency has been reported in approximately 2-3% of non-small cell lung cancers.
- Partial BRG-1 deficiency can still disrupt critical cellular pathways, leading to tumorigenesis.
- The patient experienced rapid progression to brain metastasis despite aggressive treatment.
- Comprehensive molecular profiling is important for guiding treatment decisions.
Takeaway
This study is about a man with lung cancer who had a specific gene problem that made his cancer grow quickly, even after treatment.
Methodology
Immunohistochemistry, next-generation sequencing, and PD-L1 expression analysis were performed to characterize the tumor.
Limitations
The study is based on a single case, which may not represent broader patient populations.
Participant Demographics
66-year-old male with a 40-year smoking history.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website